SEC Form 4/A · accession 0001213900-26-086697
Tiziana Life Sciences Ltd · TLSA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Gabriele M Cerrone
Director · 10% Owner
Period of report
Jul 21, 2026
Accepted (ET)
Aug 7, 2026 · 4:16 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001723069
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | Jul 21, 2026 | P | 42,357 | $0.99 | A | 44,814,587 | I | Via Panetta Partners Limited |
Table II — derivative securities
No Table II lines on this filing.
Remarks
This Form 4/A amends the Form 4 filed on June 23, 2026 solely to correct the date of the earliest transaction and the transaction code associated with this open market purchase. No other reported transactions are affected by this amendment.